Can-Fite Biopharma (CANF.TA) Q1 2026 Earnings

26MarConfirmed
Q4 2024
Q2 2025
Q3 2025
Q1 2026
-932.04
-621.36
-310.68
0

Details

Expected EPS
0
Actual EPS
-932.0364
Surprise EPS
-932.04
Surprise Percent
+∞%

Description

Can-Fite Biopharma (CANF.TA) has reported earnings of -932.0364 per share for Q1 2026.

0 Comments

Share your thoughts